K. Audhya Paul's most recent trade in KalVista Pharmaceuticals Inc was a trade of 5,000 Restricted Stock Unit done . Disclosure was reported to the exchange on Aug. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2025 | 5,000 | 55,000 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2025 | 5,000 | 124,841 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 13.42 per share. | 22 Aug 2025 | 2,336 | 122,505 (0%) | 0% | 13.4 | 31,349 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2025 | 6,250 | 122,783 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2025 | 6,250 | 87,500 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 13.22 per share. | 21 Aug 2025 | 2,942 | 119,841 (0%) | 0% | 13.2 | 38,901 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2025 | 6,446 | 119,472 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2025 | 4,028 | 4,028 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 13.19 per share. | 17 Aug 2025 | 2,939 | 116,533 (0%) | 0% | 13.2 | 38,757 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2025 | 2,418 | 7,257 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 5,000 | 115,172 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 5,000 | 60,000 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.31 per share. | 22 May 2025 | 2,146 | 113,026 (0%) | 0% | 11.3 | 24,272 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 6,250 | 93,750 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 6,250 | 112,861 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.88 per share. | 21 May 2025 | 2,689 | 110,172 (0%) | 0% | 11.9 | 31,933 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2025 | 6,447 | 109,387 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2025 | 4,028 | 8,056 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.84 per share. | 17 May 2025 | 2,776 | 106,611 (0%) | 0% | 11.8 | 32,876 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2025 | 2,419 | 9,675 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 100,000 | 100,000 | - | - | Restricted Stock Units | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 5,000 | 105,334 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 5,000 | 65,000 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.02 per share. | 22 Feb 2025 | 2,394 | 102,940 (0%) | 0% | 10.0 | 23,988 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2025 | 6,447 | 103,459 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2025 | 4,028 | 12,084 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.82 per share. | 17 Feb 2025 | 3,125 | 100,334 (0%) | 0% | 9.8 | 30,701 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2025 | 2,419 | 12,094 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Audhya K. Paul | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 5,000 | 70,000 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 5,000 | 99,199 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.87 per share. | 22 Nov 2024 | 2,187 | 97,012 (0%) | 0% | 9.9 | 21,586 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2024 | 18,531 | 102,276 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2024 | 12,084 | 0 | - | - | Performance Stock Units | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.26 per share. | 17 Nov 2024 | 8,077 | 94,199 (0%) | 0% | 9.3 | 74,766 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2024 | 4,028 | 16,112 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2024 | 2,419 | 14,513 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2024 | 5,000 | 75,000 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2024 | 5,000 | 85,880 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.40 per share. | 22 Aug 2024 | 2,135 | 83,745 (0%) | 0% | 12.4 | 26,474 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2024 | 18,528 | 88,853 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2024 | 12,083 | 12,084 | - | - | Performance Stock Units | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 17 Aug 2024 | 7,973 | 80,880 (0%) | 0% | 12.0 | 95,782 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2024 | 4,027 | 20,140 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2024 | 2,418 | 16,932 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 80,000 | 80,000 | - | - | Restricted Stock Units | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 30,614 | 83,500 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.76 per share. | 17 May 2024 | 13,175 | 70,325 (0%) | 0% | 11.8 | 154,997 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 12,084 | 0 | - | - | Performance Stock Units | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 12,083 | 24,167 | - | - | Performance Stock Units | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 4,028 | 24,167 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 2,419 | 19,350 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Audhya K. Paul | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 30,613 | 67,181 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 14.12 per share. | 17 Feb 2024 | 14,295 | 52,886 (0%) | 0% | 14.1 | 201,774 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 12,083 | 36,250 | - | - | Performance Stock Units | |
| KalVista Pharmaceuticals Inc | Audhya K. Paul | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 12,083 | 12,084 | - | - | Performance Stock Units | |
| KalVista Pharmaceuticals Inc | K. Audhya Paul | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 4,028 | 28,195 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | K. Audhya Paul | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 2,419 | 21,769 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Audhya Paul K. | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2024 | 48,333 | 48,333 | - | - | Performance Stock Units | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2023 | 18,529 | 34,043 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2023 | 12,083 | 0 | - | - | Performance Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.73 per share. | 17 Aug 2023 | 8,020 | 26,023 (0%) | 0% | 10.7 | 86,045 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2023 | 4,028 | 36,251 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2023 | 2,418 | 26,607 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 4,027 | 44,307 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2022 | 2,419 | 6,668 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2022 | 2,419 | 33,863 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.44 per share. | 17 Nov 2022 | 722 | 5,946 (0%) | 0% | 5.4 | 3,928 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2022 | 2,418 | 36,282 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2022 | 2,418 | 2,418 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.96 per share. | 17 Aug 2022 | 725 | 1,693 (0%) | 0% | 15.0 | 10,847 | Common Stock |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 38,700 | 38,700 | - | - | Restricted Stock Units | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 25,800 | 25,800 | - | - | Employee Stock Option (Right to Buy) | |
| KalVista Pharmaceuticals Inc | Paul K. Audhya | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2021 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) |